Darren R. Carpizo, Ph.D.
Affiliations: | 2003 | University of California, Los Angeles, Los Angeles, CA |
Area:
Molecular Biology, Medicine and SurgeryGoogle:
"Darren Carpizo"Parents
Sign in to add mentor| Luisa Iruela-Arispe | grad student | 2003 | UCLA | |
| (ADAMTS -1 /METH -1: A matrix metalloprotease that regulates tumor growth and angiogenesis by selective shedding of cell surface proteins.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Langan RC, Carpizo DR. (2019) Modernizing the clinical risk score to more accurately predict survival following resection of colorectal liver metastases. Translational Gastroenterology and Hepatology. 4: 49 |
| Zaman S, Yu X, Bencivenga AF, et al. (2019) Combinatorial therapy of Zinc metallochaperones with mutant p53 reactivation and diminished copper binding. Molecular Cancer Therapeutics |
| Ali ND, Donohue K, Zandieh S, et al. (2019) Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living ≥24 Months: A Single Institutional Study. American Journal of Clinical Oncology |
| Yu X, Carpizo DR. (2019) Flipping the "switch" on mutant p53 by zinc metallochaperones: how a brief pulse of zinc can reactivate mutant p53 to kill cancer. Oncotarget. 10: 918-919 |
| Na B, Yu X, Wither T, et al. (2019) Abstract P6-20-05: Therapeutic targeting ofBRCA1andTP53mutant breast cancer through mutant p53 reactivation Cancer Research |
| Shah MM, Rhee K, NeMoyer RE, et al. (2019) Conditional survival of patients with hepatocellular carcinoma undergoing curative intent resection: Analysis of the national cancer database Hpb. 21 |
| Yu X, Kogan S, Chen Y, et al. (2018) Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Kogan S, Carpizo DR. (2018) Zinc Metallochaperones as Mutant p53 Reactivators: A New Paradigm in Cancer Therapeutics. Cancers. 10 |
| Weiner AA, Gui B, Newman NB, et al. (2018) Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases. Journal of Vascular and Interventional Radiology : Jvir |
| Chang H, Xiao Z, Li T, et al. (2018) Abstract 2881: RET signaling in pancreatic cancer: A novel target by metformin to suppress cancer progression Cancer Research. 78: 2881-2881 |